Cargando…
Parkinson’s Disease Drug Therapies in the Clinical Trial Pipeline: 2022 Update
BACKGROUND: As the international community dealt with the ongoing COVID-19 pandemic, important progress continued to be made in the development of new drug-based therapies for the neurodegenerative condition of Parkinson’s disease (PD) in 2021. This progress included both “symptomatic treatments” (S...
| Autores principales: | , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
IOS Press
2022
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9198738/ https://www.ncbi.nlm.nih.gov/pubmed/35527571 http://dx.doi.org/10.3233/JPD-229002 |